Résumé
La neuralgia posherpética (NPH) es la principal complicación del herpes zoster (HZ), el cual normalmente cursa con dolor y rash por un par de semanas, sin embargo un porcentaje importante de personas presentan dolor de tipo neuropático, prolongado y de difícil manejo clínico, cuadro denominado NPH. Al igual que en el HZ, la incidencia de la NPH aumenta en personas mayores, aspecto relevante, ya que a pesarde los múltiples manejos disponibles, ninguno se considera 100% eficaz. El objetivo principal de esta revisión eshacer un análisis de los elementos farmacológicos y no farmacológicos disponibles para el manejo de la NPH.
Postherpetic neuralgia is the primary complication of the herpes zoster (HZ) a condition that usually courses with a rash and neuropathic intensive pain for limited time; despite of this fact there are a large percentage of individuals that present a prolonged pain, which hampers the clinical management, profile considered as PHN. As well as NPH the incidence of HZ has been found to be much higher in elders, this is considered relevant due to the fact that, although the therapeutics available are extensive, none offer 100% efficiency; the purposeof this review is to make an analysis of the pharmaceuticals and not pharmaceutical elements availablenowadays to manage PHN.